Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.

Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE.

Clin Infect Dis. 2001 Oct 15;33(8):1417-23. Epub 2001 Sep 5.

PMID:
11550118
[PubMed - indexed for MEDLINE]
Free PMC Article
2.
3.

Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting.

Thirumurthy H, Siripong N, Vreeman RC, Pop-Eleches C, Habyarimana JP, Sidle JE, Siika AM, Bangsberg DR.

AIDS. 2012 Nov 28;26(18):2399-403. doi: 10.1097/QAD.0b013e328359aa68.

PMID:
22948266
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE.

J Gen Intern Med. 2002 May;17(5):377-81.

PMID:
12047736
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.

Llabre MM, Weaver KE, Durán RE, Antoni MH, McPherson-Baker S, Schneiderman N.

AIDS Patient Care STDS. 2006 Oct;20(10):701-11.

PMID:
17052140
[PubMed - indexed for MEDLINE]
6.

Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.

Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentré F, Goujard C.

Antimicrob Agents Chemother. 2013 May;57(5):2265-71. doi: 10.1128/AAC.02605-12. Epub 2013 Mar 4.

PMID:
23459496
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.

Walsh JC, Mandalia S, Gazzard BG.

AIDS. 2002 Jan 25;16(2):269-77.

PMID:
11807312
[PubMed - indexed for MEDLINE]
8.

Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.

Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH.

Addiction. 2004 Mar;99(3):361-8.

PMID:
14982549
[PubMed - indexed for MEDLINE]
9.

Drug use and medication adherence among HIV-1 infected individuals.

Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, Myers HF, Longshore D.

AIDS Behav. 2007 Mar;11(2):185-94.

PMID:
16897351
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women.

Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, Stone VE, Smith DK, Schoenbaum EE; HER Study Group.

AIDS. 2002 Nov 8;16(16):2175-82.

PMID:
12409739
[PubMed - indexed for MEDLINE]
11.

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.

Applebaum AJ, Reilly LC, Gonzalez JS, Richardson MA, Leveroni CL, Safren SA.

AIDS Patient Care STDS. 2009 Jun;23(6):455-62. doi: 10.1089/apc.2008.0181.

PMID:
19519229
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.

Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):4-8.

PMID:
17460469
[PubMed - indexed for MEDLINE]
13.

Barriers to use of electronic adherence monitoring in an HIV clinic.

Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ.

Ann Pharmacother. 2001 Sep;35(9):1010-5.

PMID:
11573846
[PubMed - indexed for MEDLINE]
14.

Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.

Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, Iwebor HU, Stiekema J.

Eur J Clin Pharmacol. 2007 Dec;63(12):1115-21. Epub 2007 Sep 20.

PMID:
17882408
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Assessment of adherence to HIV protease inhibitors: comparison and combination of various methods, including MEMS (electronic monitoring), patient and nurse report, and therapeutic drug monitoring.

Hugen PW, Langebeek N, Burger DM, Zomer B, van Leusen R, Schuurman R, Koopmans PP, Hekster YA.

J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):324-34.

PMID:
12131570
[PubMed - indexed for MEDLINE]
16.

Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues.

Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP.

AIDS Behav. 2007 Mar;11(2):161-73.

PMID:
16804749
[PubMed - indexed for MEDLINE]
17.

Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study.

de Bruin M, Hospers HJ, van den Borne HW, Kok G, Prins JM.

AIDS Patient Care STDS. 2005 Jun;19(6):384-94.

PMID:
15989434
[PubMed - indexed for MEDLINE]
18.

Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.

Fairley CK, Permana A, Read TR.

HIV Med. 2005 Sep;6(5):366-9.

PMID:
16156886
[PubMed - indexed for MEDLINE]
19.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
[PubMed - indexed for MEDLINE]
20.

Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients.

Buscher A, Hartman C, Kallen MA, Giordano TP.

HIV Clin Trials. 2011 Sep-Oct;12(5):244-54. doi: 10.1310/hct1205-244.

PMID:
22180522
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk